We are live on ! Find out more
HCM

Highbridge Capital Management Portfolio holdings

AUM $3.09B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
+2.73%
1 Year Est. Return
+31.19%
3 Year Est. Return
+54.53%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.39%
AUM
$8.22B
AUM Growth
+$272M
Cap. Flow
-$981M
Cap. Flow %
-11.94%
Top 10 Hldgs %
21.98%
Holding
1,489
New
477
Increased
218
Reduced
244
Closed
468

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$64.1M
2
META icon
Meta Platforms (Facebook)
META
+$58.9M
3
MON
Monsanto Co
MON
+$54.7M
4
CELG
Celgene Corp
CELG
+$53.6M
5
TGT icon
Target
TGT
+$52.1M

Sector Composition

Rank Sector Weight
1 Consumer Staples 9.92%
2 Healthcare 9.35%
3 Technology 6.84%
4 Consumer Discretionary 5.39%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASH icon
526
Ashland
ASH
$3.33B
$884K 0.01%
16,628
+9,805
+144% +$489K
TEX icon
527
Terex
TEX
$7.18B
$873K 0.01%
+21,250
New +$864K
SMTC icon
528
Semtech
SMTC
$11B
$871K 0.01%
+33,325
New +$838K
BBQ
529
CALL
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
$861K 0.01%
+30,000
New +$867K
SPNC
530
PUT
DELISTED
Spectranetics Corp
SPNC
$858K 0.01%
+37,500
New +$870K
PKD
531
DELISTED
Parker Drilling Company
PKD
$852K 0.01%
8,713
+7,995
+1,114% +$792K
PRFT
532
DELISTED
Perficient Inc
PRFT
$848K 0.01%
+43,560
New +$789K
NVAX icon
533
Novavax
NVAX
$1.2B
$847K 0.01%
9,159
+8,642
+1,672% +$760K
CRAY
534
PUT
DELISTED
Cray, Inc.
CRAY
$846K 0.01%
31,800
+18,900
+147% +$546K
LULU icon
535
lululemon athletica
LULU
$13.5B
$838K 0.01%
+20,703
New +$944K
EZPW icon
536
Ezcorp Inc
EZPW
$1.83B
$836K 0.01%
72,385
+51,399
+245% +$587K
EBS icon
537
Emergent Biosolutions
EBS
$373M
$833K 0.01%
37,102
+8,189
+28% +$191K
DBD
538
CALL
DELISTED
Diebold Nixdorf Incorporated
DBD
$827K 0.01%
20,600
-200
-1% -$7.67K
RL icon
539
PUT
Ralph Lauren
RL
$22.6B
$820K 0.01%
5,100
-3,300
-39% -$509K
PZZA icon
540
Papa John's
PZZA
$984M
$817K 0.01%
+19,285
New +$857K
DRIV
541
DELISTED
DIGITAL RIVER INC.
DRIV
$817K 0.01%
+52,968
New +$843K
WMB icon
542
Williams Companies
WMB
$87.5B
$816K 0.01%
14,016
-40,121
-74% -$1.86M
CAMP
543
PUT
DELISTED
CalAmp Corp.
CAMP
$816K 0.01%
1,639
-352
-18% -$165K
IHS
544
DELISTED
IHS INC CL-A COM STK
IHS
$814K 0.01%
+6,002
New +$749K
EVR icon
545
Evercore
EVR
$12.4B
$813K 0.01%
+14,099
New +$774K
XPO icon
546
CALL
XPO
XPO
$23.5B
$809K 0.01%
+81,826
New +$748K
CMA
547
PUT
DELISTED
Comerica
CMA
$807K 0.01%
16,100
+200
+1% +$9.77K
CPRT icon
548
Copart
CPRT
$27B
$803K 0.01%
+178,672
New +$805K
RJF icon
549
Raymond James Financial
RJF
$33.8B
$799K 0.01%
+23,609
New +$788K
CDE icon
550
Coeur Mining
CDE
$15.4B
$798K 0.01%
86,875
-236,699
-73% -$1.95M

Similar funds

Highbridge Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Highbridge Capital Management held 1,489 positions worth $8.22B, up 3.4% from $7.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Highbridge Capital Management withdrew a net $981M in Q2 2014, closing 468 positions and reducing 244 holdings. Its most notable exit was Celgene Corp, an estimated $53.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 9.9% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Highbridge Capital Management opened a new position in Bausch Health worth $38.6M.

  • Highbridge Capital Management's largest Q2 2014 buy was Bausch Health: 305,899 shares worth $38.6M.
  • Highbridge Capital Management added most to Citigroup in Q2 2014, an estimated $57.9M increase.
  • Highbridge Capital Management's biggest Q2 2014 reduction was Intel, cutting an estimated $64.1M.
  • Highbridge Capital Management fully exited Celgene Corp in Q2 2014, selling an estimated $53.6M.
  • Highbridge Capital Management's ten largest holdings make up 22% of its $8.22B portfolio in Q2 2014.
  • Highbridge Capital Management opened 477 new positions and closed 468 in Q2 2014.
  • Highbridge Capital Management's portfolio value rose 3.4% quarter-over-quarter to $8.22B.

Based on Highbridge Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.